Montreal, Canada

Michele Boushira

This inventor holds 1 USPTO granted patent. Top assignee: Theratechnologies Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michele Boushira. Retrieved from https://idiyas.com/inventor/michele-boushira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 103(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michele Boushira: Innovator in Platelet Growth Factors

Introduction

Michele Boushira is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biotechnology, particularly in the preparation of platelet growth factors. His innovative work has the potential to impact various medical applications.

Latest Patents

Michele Boushira holds a patent for a process titled "Process for the preparation of platelet growth factors extract." This invention involves a detailed method for preparing porcine platelet-extract containing matured growth factors. The process includes several steps: centrifuging whole porcine blood to isolate platelets, resuspending and concentrating the platelets, washing them, and finally lyophilizing the washed platelets to produce an optimal platelet extract.

Career Highlights

Boushira is associated with Theratechnologies Inc., a company focused on developing innovative therapies. His work at the company highlights his commitment to advancing medical science through research and development.

Collaborations

Michele collaborates with talented individuals such as Michel Ibea and Paul Brazeau. Their teamwork contributes to the innovative environment at Theratechnologies Inc.

Conclusion

Michele Boushira's contributions to the field of biotechnology, particularly through his patent on platelet growth factors, showcase his dedication to innovation. His work has the potential to lead to significant advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…